What is Zacks Research’s Estimate for MRSH FY2026 Earnings?

Marsh & McLennan Companies, Inc. (NYSE:MRSH) – Equities research analysts at Zacks Research upped their FY2026 earnings per share estimates for Marsh & McLennan Companies in a research report issued to clients and investors on Thursday, November 5th. Zacks Research analyst Team now expects that the financial services provider will post earnings of $10.43 per share for the year, up from their prior estimate of $10.40. The consensus estimate for Marsh & McLennan Companies’ current full-year earnings is $10.48 per share. Zacks Research also issued estimates for Marsh & McLennan Companies’ Q4 2026 earnings at $2.15 EPS, Q1 2027 earnings at $3.50 EPS, Q2 2027 earnings at $3.10 EPS, Q3 2027 earnings at $2.19 EPS, Q4 2027 earnings at $2.59 EPS, FY2027 earnings at $11.39 EPS, Q1 2028 earnings at $3.77 EPS, Q2 2028 earnings at $3.43 EPS, Q3 2028 earnings at $2.34 EPS and FY2028 earnings at $12.28 EPS.

Other analysts have also issued reports about the stock. Mizuho upped their price objective on shares of Marsh & McLennan Companies from $190.00 to $200.00 and gave the stock a “neutral” rating in a research note on Monday, October 19th. UBS Group raised their target price on shares of Marsh & McLennan Companies from $216.00 to $222.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Bank of America reduced their price target on shares of Marsh & McLennan Companies from $179.00 to $178.00 and set an “underperform” rating for the company in a report on Wednesday, July 15th. BMO Capital Markets raised shares of Marsh & McLennan Companies from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $204.00 to $230.00 in a research report on Tuesday. Finally, Morgan Stanley dropped their price objective on shares of Marsh & McLennan Companies from $200.00 to $180.00 and set an “equal weight” rating on the stock in a research note on Tuesday, October 6th. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Marsh & McLennan Companies presently has an average rating of “Hold” and a consensus target price of $205.84.

Marsh & McLennan Companies Price Performance

MRSH stock opened at $209.63 on Friday. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.09 and a quick ratio of 1.09. The company has a 50-day moving average price of $183.48. The company has a market capitalization of $99.68 billion, a P/E ratio of 25.07, a P/E/G ratio of 2.84 and a beta of 0.53. Marsh & McLennan Companies has a 1-year low of $156.60 and a 1-year high of $214.00.

Marsh & McLennan Companies (NYSE:MRSH) last released its quarterly earnings data on Thursday, October 15th. The financial services provider reported $2.03 EPS for the quarter, topping the consensus estimate of $1.96 by $0.07. Marsh & McLennan Companies had a return on equity of 33.32% and a net margin of 14.20%. The company had revenue of $6.86 billion for the quarter. The business’s quarterly revenue was up 8.1% on a year-over-year basis.

Marsh & McLennan Companies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Thursday, October 1st will be given a dividend of $0.99 per share. The ex-dividend date of this dividend is Thursday, October 1st. This represents a $3.96 dividend on an annualized basis and a yield of 1.9%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 47.37%.

Insider Activity

In other Marsh & McLennan Companies news, VP Stacy Mills sold 1,215 shares of the stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $200.00, for a total transaction of $243,000.00. Following the completion of the sale, the vice president directly owned 2,705 shares of the company’s stock, valued at approximately $541,000. This represents a 30.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Dean Klisura sold 4,194 shares of the firm’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $200.00, for a total transaction of $838,800.00. Following the completion of the sale, the chief executive officer owned 20,935 shares in the company, valued at $4,187,000. This represents a 16.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by insiders.

Institutional Investors Weigh In On Marsh & McLennan Companies

A number of hedge funds and other institutional investors have recently bought and sold shares of MRSH. Asset Dedication LLC purchased a new stake in Marsh & McLennan Companies during the 1st quarter valued at about $25,000. Quest 10 Wealth Builders Inc. lifted its stake in Marsh & McLennan Companies by 95.0% in the 3rd quarter. Quest 10 Wealth Builders Inc. now owns 156 shares of the financial services provider’s stock worth $27,000 after purchasing an additional 76 shares in the last quarter. EFG International AG purchased a new position in Marsh & McLennan Companies in the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc purchased a new position in Marsh & McLennan Companies in the 2nd quarter worth approximately $31,000. Finally, Gen Wealth Partners Inc acquired a new position in shares of Marsh & McLennan Companies during the 3rd quarter worth approximately $33,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Marsh & McLennan Companies News Summary

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Analyst upgrade: BMO Capital Markets raised Marsh & McLennan to Outperform, a more favorable recommendation that may support investor sentiment. Article: Marsh & McLennan Companies Raised to Outperform at BMO Capital Markets
• Positive Sentiment: Mostly higher earnings forecasts: Zacks Research raised its estimates for full-year 2026, 2027, and 2028 EPS to $10.43, $11.39, and $12.28, respectively. It also lifted several quarterly forecasts, including Q2 2027 and Q4 2027, signaling a modestly improved earnings outlook overall.
• Positive Sentiment: Retirement business initiative: Marsh introduced BrightPath, a retirement solution with $116 billion in assets under management across six markets. The offering could expand the company’s retirement business and recurring fee income. Article: Marsh Unveils BrightPath Retirement Solution With $116B in AUM
• Positive Sentiment: Acquisition completed: Marsh completed its acquisition of AltamarCAM, adding to its investment and advisory capabilities. A separate analysis said the stock may be 27% undervalued following the deal, though that represents an analyst view rather than a company forecast. Article: Marsh Completes Acquisition of AltamarCAM Article: Marsh Stock May Be 27% Undervalued Following AltamarCAM Deal
• Neutral Sentiment: Leadership appointments: Marsh named Marcus Baker chairman and Michael Walls global head of Marine, Cargo, and Logistics. The changes may be relevant to execution but do not by themselves indicate a clear near-term earnings impact. Article: Marsh & McLennan Appoints Marcus Baker and Michael Walls
• Negative Sentiment: Zacks Research lowered its Q4 2026 EPS estimate to $2.15 from $2.19 and its Q3 2027 estimate to $2.19 from $2.21, tempering the broadly positive revisions.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies is a global professional services firm that provides advice and solutions in risk, strategy and people. The company serves businesses, governments and institutions through a portfolio of specialized businesses focused on insurance brokerage, reinsurance, consulting and talent management.

Its principal businesses include Marsh, an insurance brokerage and risk advisory firm; Guy Carpenter, a provider of reinsurance brokerage and related risk-management services; Mercer, which offers consulting in investment, retirement, health and workforce strategy; and Oliver Wyman, a management consulting firm serving clients across industries and regions.

Founded in 1905, Marsh & McLennan serves clients in countries and markets around the world.